Daratumumab has been known to be effective in relapsed myeloma for a long time.
Yet it was mostly not given to the control arm upon progression in trials of newly diagnosed myeloma.
This is a preventable tragedy- that we must avoid repeating.
For article: Click here
Source: Manni Mohyuddin/ Twitter